SPRO (Spero Therapeutics, Inc. Common Stock) Stock Analysis - Analyst Ratings

Spero Therapeutics, Inc. Common Stock (SPRO) is a publicly traded Healthcare sector company. As of May 21, 2026, SPRO trades at $2.60 with a market cap of $149.39M and a P/E ratio of 0.00. SPRO moved +1.16% today. Year to date, SPRO is +8.23%; over the trailing twelve months it is +286.65%. Its 52-week range spans $0.51 to $3.22. Rallies surfaces SPRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate SPRO?

The average price target is $0.00.

SPRO Key Metrics

Key financial metrics for SPRO
MetricValue
Price$2.60
Market Cap$149.39M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$3.22
52-Week Low$0.51
Volume0
Avg Volume0
Revenue (TTM)$13.51M
Net Income$-525.95K
Gross Margin57.80%

SPRO Analyst Consensus

SPRO analyst coverage data. Average price target: $0.00.

Latest SPRO News

Recent SPRO Insider Trades

  • Rajavelu Esther sold 25.24K (~$63.35K) on May 4, 2026.
  • Rajavelu Esther sold 37.10K (~$87.56K) on Feb 6, 2026.
  • Rajavelu Esther sold 50.82K (~$119.93K) on Feb 6, 2026.

Common questions about SPRO

What do analysts rate SPRO?
The average price target is $0.00.
Does Rallies show SPRO price targets?
Yes. Rallies tracks SPRO analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is SPRO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SPRO. It does not provide personalized investment advice.
SPRO

SPRO